GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » Debt-to-Asset

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Debt-to-Asset : 0.00 (As of Dec. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Health Sciences Acquisitions 2 Debt-to-Asset?

Health Sciences Acquisitions 2's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Health Sciences Acquisitions 2's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was $0.00 Mil. Health Sciences Acquisitions 2's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2022 was $68.08 Mil. Health Sciences Acquisitions 2's debt to asset for the quarter that ended in Dec. 2022 was 0.00.

Health Sciences Acquisitions 2 Debt-to-Asset Historical Data

The historical data trend for Health Sciences Acquisitions 2's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Sciences Acquisitions 2 Debt-to-Asset Chart

Health Sciences Acquisitions 2 Annual Data
Trend Dec20 Dec21 Dec22
Debt-to-Asset
- - -

Health Sciences Acquisitions 2 Quarterly Data
May20 Sep20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Health Sciences Acquisitions 2's Debt-to-Asset

For the Shell Companies subindustry, Health Sciences Acquisitions 2's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Health Sciences Acquisitions 2's Debt-to-Asset Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Health Sciences Acquisitions 2's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Health Sciences Acquisitions 2's Debt-to-Asset falls into.


Health Sciences Acquisitions 2 Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Health Sciences Acquisitions 2's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0 + 0) / 68.076
=0.00

Health Sciences Acquisitions 2's Debt-to-Asset for the quarter that ended in Dec. 2022 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(0 + 0) / 68.076
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Acquisitions 2  (NAS:HSAQ) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Health Sciences Acquisitions 2 Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Health Sciences Acquisitions 2's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Health Sciences Acquisitions 2 (Health Sciences Acquisitions 2) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Health Sciences Acquisitions Corp 2 (NAS:HSAQ) » Definitions » Debt-to-Asset
Comparable Companies
SAMA AACI BSAQ RCAC LCAP GFOR CLBR NGC HLXA TCOA GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
40, 10th Avenue, Floor 7, New York, NY, USA, 10014
Website
Health Sciences Acquisitions Corp 2 is a blank check company.
Executives
Joshua Aiello officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Eric S Fain director ONE ST JUDE MEDICAL DRIVE, ST. PAUL MN MN
Yuval Mika officer: See Remarks 150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Jason Aryeh director 11119 NORTH TORREY PINES ROAD, SUITE 200, LA JOLLA CA 92037
David P Hochman director, officer: See Remarks 15 WESTON HILL RD., RIVERSIDE CT 06878
Geoffrey Wade Smith director 6740 SHADY OAK ROAD, EDEN PRAIRIE MN 55344
Pamela Ann Connealy director 320 W 37TH STREET, 3RD FLOOR, NEW YORK NY 10016
Rose Eric A Md director 161 FORT WASHINGTON AVENUE, 7TH FLOOR, NEW YORK NY 10032
Plc Medtronic 10 percent owner 20 ON HATCH, LOWER HATCH STREET, DUBLIN L2 2
Michael Kaswan officer: Chief Financial Officer KBL HEALTHCARE ACQUISITION CORP II, 645 MADISON AVENUE, NEW YORK NY 10022
Darren Sherman director, officer: See Remarks C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Roderick Wong director, 10 percent owner, officer: Chief Executive Officer C/O RTW INVESTMENTS, LP, 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Rtw Investments, Lp 10 percent owner 40 10TH AVENUE, 7TH FLOOR, NEW YORK NY 10014
Hsac 2 Holdings, Llc 10 percent owner 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011
Stephanie A Sirota officer: VP-Corp Strategy & Corp Comms. 412 WEST 15TH STREET, FLOOR 9, NEW YORK NY 10011